588 related articles for article (PubMed ID: 23955151)
1. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
[TBL] [Abstract][Full Text] [Related]
2. Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
Más V; Rodriguez L; Olmedillas E; Cano O; Palomo C; Terrón MC; Luque D; Melero JA; McLellan JS
PLoS Pathog; 2016 Sep; 12(9):e1005859. PubMed ID: 27611367
[TBL] [Abstract][Full Text] [Related]
3. A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.
Schuster JE; Cox RG; Hastings AK; Boyd KL; Wadia J; Chen Z; Burton DR; Williamson RA; Williams JV
J Infect Dis; 2015 Jan; 211(2):216-25. PubMed ID: 24864121
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus.
Wen X; Mousa JJ; Bates JT; Lamb RA; Crowe JE; Jardetzky TS
Nat Microbiol; 2017 Jan; 2():16272. PubMed ID: 28134915
[TBL] [Abstract][Full Text] [Related]
5. Chimeric
Olmedillas E; Cano O; Martínez I; Luque D; Terrón MC; McLellan JS; Melero JA; Más V
EMBO Mol Med; 2018 Feb; 10(2):175-187. PubMed ID: 29217660
[TBL] [Abstract][Full Text] [Related]
6. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
[TBL] [Abstract][Full Text] [Related]
7. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein.
Huang J; Chopra P; Liu L; Nagy T; Murray J; Tripp RA; Boons GJ; Mousa JJ
J Virol; 2021 Aug; 95(18):e0059321. PubMed ID: 34160259
[TBL] [Abstract][Full Text] [Related]
8. Antibody Epitopes of Pneumovirus Fusion Proteins.
Huang J; Diaz D; Mousa JJ
Front Immunol; 2019; 10():2778. PubMed ID: 31849961
[TBL] [Abstract][Full Text] [Related]
9. Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site.
Wen X; Krause JC; Leser GP; Cox RG; Lamb RA; Williams JV; Crowe JE; Jardetzky TS
Nat Struct Mol Biol; 2012 Mar; 19(4):461-3. PubMed ID: 22388735
[TBL] [Abstract][Full Text] [Related]
10. Antibody recognition of the Pneumovirus fusion protein trimer interface.
Huang J; Diaz D; Mousa JJ
PLoS Pathog; 2020 Oct; 16(10):e1008942. PubMed ID: 33035266
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.
Banerjee A; Huang J; Rush SA; Murray J; Gingerich AD; Royer F; Hsieh CL; Tripp RA; McLellan JS; Mousa JJ
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2203326119. PubMed ID: 35696580
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.
Bates JT; Pickens JA; Schuster JE; Johnson M; Tollefson SJ; Williams JV; Davis NL; Johnston RE; Schultz-Darken N; Slaughter JC; Smith-House F; Crowe JE
Vaccine; 2016 Feb; 34(7):950-6. PubMed ID: 26772634
[TBL] [Abstract][Full Text] [Related]
13. Bovine model of respiratory syncytial virus infection.
Taylor G
Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697
[TBL] [Abstract][Full Text] [Related]
14. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.
Xiao X; Tang A; Cox KS; Wen Z; Callahan C; Sullivan NL; Nahas DD; Cosmi S; Galli JD; Minnier M; Verma D; Babaoglu K; Su H; Bett AJ; Vora KA; Chen Z; Zhang L
MAbs; 2019; 11(8):1415-1427. PubMed ID: 31402751
[TBL] [Abstract][Full Text] [Related]
15. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.
Zhang Y; Wei Y; Zhang X; Cai H; Niewiesk S; Li J
J Virol; 2014 Oct; 88(19):11411-29. PubMed ID: 25056882
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention.
Magro M; Mas V; Chappell K; Vázquez M; Cano O; Luque D; Terrón MC; Melero JA; Palomo C
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3089-94. PubMed ID: 22323598
[TBL] [Abstract][Full Text] [Related]
17. A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV.
Wen X; Pickens J; Mousa JJ; Leser GP; Lamb RA; Crowe JE; Jardetzky TS
PLoS One; 2016; 11(5):e0155917. PubMed ID: 27224013
[TBL] [Abstract][Full Text] [Related]
18. Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
Palomo C; Mas V; Thom M; Vázquez M; Cano O; Terrón MC; Luque D; Taylor G; Melero JA
J Virol; 2016 Jun; 90(11):5485-5498. PubMed ID: 27009962
[TBL] [Abstract][Full Text] [Related]
19. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.
Mousa JJ; Binshtein E; Human S; Fong RH; Alvarado G; Doranz BJ; Moore ML; Ohi MD; Crowe JE
PLoS Pathog; 2018 Feb; 14(2):e1006837. PubMed ID: 29470533
[TBL] [Abstract][Full Text] [Related]
20. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
